-
Symbol
-
ARWR on Nasdaq
-
Investment type
-
Equity / Common Stock
-
Latest Disclosed Shares Owned
-
20,323,221 shares
-
Security Ownership %
-
15%
Shares, Excluding Options vs Price
BlackRock, Inc. ownership in ARROWHEAD PHARMACEUTICALS, INC. Common Stock (ARWR)
21 Jan 2026 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 20,323,221 shares of ARROWHEAD PHARMACEUTICALS, INC. Common Stock (ARWR).
This represents 15% ownership of the company.
In their previous filing dated 23 Apr 2025, BlackRock, Inc. had reported owning 19,012,855 shares, indicating an increase of +6.9%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.